Welcome to the Desert Angels™. We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies. The organization serves as a forum for its over 100 members, who invest individually from their personal funds. Since 2000, Desert Angel members have invested over $29 million in more than 70 presenting companies.

Stimwave Receives FDA Clearance for World’s First Injectable Wireless MicroSize Pain Relief System for Chronic Back and Leg Pain

by gabrielsayegh on December 8th, 2014 at 5:28pm

Desert Angels portfolio company, Stimwave Technologies Incorporated; a medical device manufacturer and independent research institute headquartered in Miami Beach, Fla., has received FDA clearance to market the world’s first wireless, microtechnology neuromodulation device for relief of chronic back and leg pain. Currently being marketed throughout Europe, Stimwave announced it’s revolutionary electroceutical device will be commercially available in the U.S. as of January 2015.

Click here for the full article

Comment

Picmonic receives $1.25 million in financing from local investors

by gabrielsayegh on November 12th, 2014 at 5:50pm

Desert Angels portfolio company, Picmonic; the Tempe-based company  which develops audiovisual study cards for medical students, has closed on $1.25 million in financing from local investors. Picmonic CEO and co-founder Ron Robertson said the money will help support the company’s move into the mobile industry and open up new markets in education. This financing, which closed in September, brings the company’s total money raised to $2.6 million.

Click here for the full article

Comment

Filed under: Funded Companies

HTG Molecular Diagnostics Announces $16 Million Term Loan Agreement With Silicon Valley Bank and Oxford Finance

by gabrielsayegh on August 30th, 2014 at 8:41pm

Desert Angels portfolio company, HTG Molecular Diagnostics, announced that it has closed a growth capital term loan facility with Silicon Valley Bank and Oxford Finance. The loan facility provides HTG with up to $16 million of available proceeds, with $11 million funded at the initial closing this month.

For More: HTG Molecular Diagnostics Announces $16 Million Term Loan Agreement With Silicon Valley Bank and Oxford Finance

Comment

Gaming for good—with celebrities

by gabrielsayegh on August 30th, 2014 at 8:34pm

Fortune Magazine reported that Desert Angels portfolio company, Tiltify, capitalizes on livestreaming and opens up opportunities for celebrities, athletes and gamers to play for good causes.

For more: Gaming for good—with celebrities

Comment

Filed under: Funded Companies

Stem cell therapy could lead to HIV cure

by chrismarin on August 7th, 2014 at 4:03pm

Desert Angels portfolio company Calimmune is recognized for being at the forefont of developing a practical cure for people living with HIV infection.

Special note: The article erroneously credits the company as a San Diego based company – Calimmune is a Tucson based company.

For more: Stem cell therapy could lead to HIV cure

Comment

Filed under: Funded Companies, Press

Contatta’s collaborative email now available for free public beta testing

by chrismarin on August 6th, 2014 at 12:17am

Contatta, the Scottsdale-based creator of the email application, announced Monday it is now free for anyone who wants to sign up online. It will become a paid service in the fall. Contatta is designed to address four common problems: collaboration and discussions with others, task management, contact management and keeping files handy.

For more: Contatta’s collaborative email now available for free public beta testing

Comment

Filed under: Funded Companies, Press

Calimmune Approved to Treat Second Group in HIV Stem Cell Gene Modification Study

by Curtis Gunn on July 21st, 2014 at 5:26pm

Calimmune today announced encouraging safety data from its innovative gene-based stem cell therapy, Cal-1-being developed to help cure individuals infected with HIV. The company can now begin treating the second group of patients in the trial, which is being funded in part by a grant from the California Institute for Regenerative Medicine (CIRM).

Link to Full Article.

1 comment

HTG receives US patent for HTG EdgeSeq chemistry

by Curtis Gunn on July 21st, 2014 at 5:18pm

HTG Molecular Diagnostics, a provider of instruments and reagents for translational research and molecular diagnostics, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,741,564 claiming a method for using quantitative nuclease protection technology in combination with next-generation-sequencing.

Link to Full Article.

Comment

FDA approves SynCardia’s artificial-heart power pack

by chrismarin on July 18th, 2014 at 6:51pm

The U.S. Food and Drug Administration has given the nod to Tucson-based SynCardia Systems Inc. to begin marketing in the U.S. its Freedom portable driver that powers the company’s total artificial heart.

Not only does that mean the company will begin hiring more people to make and sell the device, but it also means reducing the length of stay in hospitals for heart transplant patients. Before SynCardia invented the Freedom portable driver, U.S. patients were stuck in the hospital for years because the power pack that charges the company’s artificial heart was too big to allow patients to move around freely.

For more: FDA approves SynCardia’s artificial-heart power pack

Comment

Filed under: Funded Companies, Press

PlayAbility Toys Provides Kids a Special Kind of Play

by chrismarin on July 9th, 2014 at 2:15am

Desert Angels portfolio company PlayAbility Toys is highlighted as one of the few companies dedicated to creating toys for special needs children.

For more: PlayAbility Toys Provides Kids a Special Kind of Play

Comment

Filed under: Funded Companies, Press